Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,124,338
+$117,238 QoQ
Shares Held
12,302
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#1,982
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $11,549,324 across 11 Drug Manufacturers - General names. JNJ ranks #2 (27.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,805 | $3,364,401 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
12,302 | $3,124,338 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,302 | $2,094,807 | |
| 4 | PFE |
Pfizer Inc
|
36,400 | $876,512 | |
| 5 | ABBV |
AbbVie Inc.
|
3,374 | $849,033 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,190 | $414,287 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,990 | $377,756 | |
| 8 | AMGN |
Amgen Inc
|
962 | $348,359 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,124,338 | 12,302 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,007,100 | 12,302 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,576,941 | 12,452 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,333,881 | 12,587 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,932,593 | 12,652 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,231,377 | 13,455 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,958,154 | 13,540 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,182,137 | 13,465 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,963,951 | 13,437 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,982,437 | 12,532 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $2,003,450 | 12,782 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,957,933 | 12,571 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $2,113,855 | 12,771 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,979,505 | 12,771 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,266,596 | 12,831 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,087,904 | 12,781 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,263,430 | 12,751 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,259,859 | 12,751 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,181,313 | 12,751 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,054,441 | 12,721 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,126,958 | 12,911 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $3,405,825 | 20,723 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,340,075 | 21,223 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $3,159,680 | 21,223 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,022,419 | 21,492 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,890,367 | 22,042 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||